These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14567455)

  • 1. History in our lifetime: the changing nature of refractory duodenal ulcer in the era of histamine H2 receptor antagonists.
    Bardhan KD; Nayyar AK; Royston C
    Dig Liver Dis; 2003 Aug; 35(8):529-36. PubMed ID: 14567455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of refractory gastric ulcer using H2-receptor antagonists.
    Raju GS; Bardhan KD; Royston C; Beresford J
    Aliment Pharmacol Ther; 1996 Jun; 10(3):387-96. PubMed ID: 8791968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome of bleeding duodenal ulcer in the era of H2 receptor antagonist therapy.
    Bardhan KD; Nayyar AK; Royston C
    QJM; 1998 Mar; 91(3):231-7. PubMed ID: 9604075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there any acid peptic disease that is refractory to proton pump inhibitors?
    Bardhan KD
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
    Sevvel S; Ananthakrishnan N; Kate V
    Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant gastric ulcer: its natural history and outcome in the H2RA era.
    Raju GS; Bardhan KD; Royston C; Beresford J
    Am J Gastroenterol; 1999 Dec; 94(12):3478-86. PubMed ID: 10606307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H2-receptor antagonists: development and application.
    Feldman S
    N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of perforated and bleeding peptic ulcers before and after the introduction of H2-receptor antagonists.
    Christensen A; Bousfield R; Christiansen J
    Ann Surg; 1988 Jan; 207(1):4-6. PubMed ID: 2892468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
    Khasawneh SM; Affarah HB
    Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
    Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
    Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine2-receptor antagonists in gastroduodenal ulcer haemorrhage.
    Falk A; Darle N; Haglund U; Törnqvist A
    Scand J Gastroenterol Suppl; 1985; 110():95-100. PubMed ID: 2862700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.
    Walt RP; Trotman IF; Frost R; Golding PL; Shepherd TH; Rawlings J; Hunt RH; Colin-Jones D; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Apr; 22(4):319-22. PubMed ID: 6113192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
    Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis.
    Palmer RH; Frank WO; Karlstadt R
    Aliment Pharmacol Ther; 1990 Jun; 4(3):283-94. PubMed ID: 1983324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
    Di Mario F; Gottardello L; Germanà B; Dotto P; Grassi SA; Vianello F; Battaglia G; Leandro G; Burra P; Salvagnini M
    Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
    Young MD; Lottes SR; Webb LA
    Clin Ther; 1988; 10(5):543-52. PubMed ID: 2856597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the H2 receptor antagonists change the natural history of duodenal ulcer disease?
    Bardhan KD
    Am J Gastroenterol; 1994 Jan; 89(1):3-6. PubMed ID: 7903845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.